车站3
癌症研究
Janus激酶2
细胞生长
STAT蛋白
化学
信号转导
肝细胞癌
福克斯O1
转录因子
磷酸化
生物
基因
生物化学
蛋白激酶B
作者
Jinhai Li,Mengchen Ge,Pengcheng Deng,Xinquan Wu,Longqing Shi,Yang Yu
标识
DOI:10.1080/08923973.2023.2247552
摘要
AbstractObjective: This study aimed to investigate the underlying molecular mechanisms of Withaferin A (WA) in hepatocellular carcinoma (HCC).Materials and Methods: The gene and protein expression were analyzed using RT-qPCR and western blot, respectively. The proliferation of HCC cells was evaluated by CCK-8 assays. The migrative ability of HCC cells was measured by transwell assays.Results: We revealed that WA suppressed the proliferation and migration of HCC cells and inhibited IGF2BP3 (insulin like growth factor 2 mRNA binding protein 3) expression. IGF2BP3 abundance reversed the reactive oxygen species (ROS) accumulation and suppression of HCC cell proliferation and migration induced by WA. Besides, IGF2BP3 suppressed ROS production to promote the growth and migration of HCC cells. Furthermore, we found that IGF2BP3 exerted its tumor-promotive and ROS-suppressive effect on HCC cells by regulating the expression of FOXO1 (forkhead box O1). In addition, IGF2BP3-stimulated activation of JAK2 (Janus kinase 2)/STAT3 (signal transducer and activator of transcription 3) phosphorylation effectively decreased the transcription of FOXO1. FOXO1 abundance decreased the phosphorylation of JAK2 and STAT3 by increasing ROS level, forming a feedback loop for the inhibition of JAK2/STAT3 signaling activated by IGF2BP3.Conclusions: WA-induced ROS inhibited HCC cell growth and migration through the inhibition of IGF2BP3 to deactivate JAK2/STAT3 signaling, resulting in increased FOXO1 expression to further stimulate ROS production and inhibit JAK2/STAT3 signaling.Keywords: Withaferin AIGF2BP3FOXO1ROSJAK2/STAT3 signalinghepatocellular carcinoma Competing interestsThe authors declare that they have no competing interests.Disclosure statementNo potential conflict of interest was reported by the authors.Data availability statementThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.Additional informationFundingThis work was funded by The Medical and Health Research Project of Zhejiang Province (2022KY353), Young Talent Development Plan of Changzhou Health Commission (CZQM2020049), Applied Basic Research of Changzhou Technology Bureau (CJ20220118).
科研通智能强力驱动
Strongly Powered by AbleSci AI